Beryl Drugs Limited announced unaudited earnings results for the three months ended June 30, 2018. For the quarter, the company reported net sales or revenue from operations of INR 41,402,000 against INR 48,470,000 a year ago. Profit from operations before exceptional and extraordinary items and tax was INR 2,524,000 compared to INR 1,287,000 a year ago. Profit before was INR 2,524,000 compared to INR 1,287,000 a year ago. Net profit for the period from continuing operations was INR 2,024,000 compared to INR 967,000 a year ago. Net profit for the period was INR 2,024,000 or INR 0.399 basic and diluted per share before and after extraordinary items against INR 967,000 or INR 0.191 basic and diluted per share before and after extraordinary items a year ago.